# Immunotherapy With CD19 CART-cells for B Cell Acute Lymphoblastic Leukemia

> **NCT03599375** · PHASE1 · UNKNOWN · sponsor: **jiuwei cui** · enrollment: 20 (estimated)

## Conditions studied

- Leukemia, B-Cell

## Interventions

- **BIOLOGICAL:** CD19-targeted CART cells

## Key facts

- **NCT ID:** NCT03599375
- **Lead sponsor:** jiuwei cui
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-01
- **Primary completion:** 2020-12-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2019-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03599375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03599375, "Immunotherapy With CD19 CART-cells for B Cell Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03599375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*